LY2457546 [908265-94-1]

TargetMol Chemicals

LY2457546 [908265-94-1]

72

908265-94-1

Chemical

LY2457546

C28H20F4N4O

504.48

LY2457546 is a potent and orally bioavailable inhibitor of multiple receptor tyrosine kinases involved in angiogenic and tumorigenic signalling. LY2457546 demonstrates potent activity against targets that include VEGFR2 (KDR), PDGFRbeta, FLT-3, Tie-2 and members of the Eph family of receptors. In vivo, LY2457546 inhibited VEGF-driven autophosphorylation of lung KDR in the mouse and rat in a dose and concentration dependent manner. LY2457546 was well tolerated and exhibited efficacy in a 13762 syngeneic rat mammary tumor models. Additionally, LY2457546 caused complete regression of well-established tumors in an acute myelogenous leukemia (AML) FLT3-ITD mutant xenograft tumor model. The unique spectrum of target activity, potent in vivo anti-tumor efficacy in a variety of rodent and human solid tumor models, exquisite potency against a clinically relevant model of AML, and non-clinical safety profile justify the advancement of LY2457546 into clinical testing. (source: Invest New D......

3 years

FC=1C=C(C=2N3C(C=C(C=C3)C=4C=C(C)N=CC4)=NC2)C=CC1CC(NC5=CC(C(F)(F)F)=CC=C5)=O

-20°C

12352200